_1777370220974_847775619.png&w=48&q=75){kind=small}
History of the First Cannabis Painkiller
A German pharmaceutical company has received approval to market Exilby, the world's first cannabis-based medication for chronic pain, in Germany. The drug, derived from a proprietary marijuana strain, has demonstrated greater effectiveness than opioids and placebo in clinical trials. The company aims to expand approval across Europe and ultimately in the U.S., where there is a significant market for non-opioid pain treatments, and has begun Phase III trials there. The founder considers Exilby a potential game-changer in replacing addictive opioids for chronic pain relief.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)